Accelerated immunisation with diphtheria-tetanus-pertussis vaccine.
作者信息
Preston N W
出版信息
BMJ. 1991 Jul 27;303(6796):248. doi: 10.1136/bmj.303.6796.248.
Abstract
摘要
相似文献
1
Accelerated immunisation with diphtheria-tetanus-pertussis vaccine.
BMJ. 1991 Jul 27;303(6796):248. doi: 10.1136/bmj.303.6796.248.
2
Persistence of antibody after accelerated immunisation with diphtheria/tetanus/pertussis vaccine.白喉/破伤风/百日咳疫苗加速免疫后抗体的持续性。
BMJ. 1991 Jun 22;302(6791):1489-91. doi: 10.1136/bmj.302.6791.1489.
3
Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).预防青少年破伤风、白喉和百日咳：破伤风类毒素、白喉类毒素含量降低的无细胞百日咳疫苗的使用——免疫实践咨询委员会（ACIP）的建议
MMWR Recomm Rep. 2006 Mar 24;55(RR-3):1-34.
4
Symptoms after accelerated immunisation.加速免疫后的症状。
BMJ. 1992 Jun 13;304(6841):1534-6. doi: 10.1136/bmj.304.6841.1534.
5
Accelerated immunisation with diphtheria-tetanus-pertussis vaccine.
BMJ. 1991 Sep 14;303(6803):648-9. doi: 10.1136/bmj.303.6803.648-c.
6
Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.5 岁时接种过 3、5、11 月龄六联苗（DTaP-HBV-IPV/Hib）的儿童的免疫持久性。
Hum Vaccin Immunother. 2014;10(10):2795-8. doi: 10.4161/21645515.2014.970494.
7
Diphtheria, tetanus, and pertussis: guidelines for vaccine prophylaxis and other preventive measures. Recommendation of the Immunization Practices Advisory Committee. Centers for Disease Control, Department of Health and Human Services.白喉、破伤风和百日咳：疫苗预防及其他预防措施指南。免疫实践咨询委员会的建议。美国卫生与公众服务部疾病控制中心
Ann Intern Med. 1985 Dec;103(6 ( Pt 1)):896-905.
8
Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.青少年百日咳的预防：破伤风类毒素、白喉类毒素减少量及无细胞百日咳（Tdap）疫苗的使用建议
Pediatrics. 2006 Mar;117(3):965-78. doi: 10.1542/peds.2005-3038. Epub 2005 Dec 28.
9
Decennial administration in young adults of a reduced-antigen content diphtheria, tetanus, acellular pertussis vaccine containing two different concentrations of aluminium.对年轻成年人进行为期十年的含有两种不同铝浓度的低抗原含量白喉、破伤风、无细胞百日咳疫苗接种管理。
Vaccine. 2015 Jun 12;33(26):3026-34. doi: 10.1016/j.vaccine.2014.10.049. Epub 2015 Jan 19.
10
Humoral immunity of dTap-IPV vaccine (REPEVAX®) administered one month after dT-IPV vaccine (REVAXIS®) in adults with unknown vaccination history.在接种史不明的成人中，于吸附无细胞百白破-灭活脊髓灰质炎疫苗（REVAXIS®）接种后1个月接种吸附无细胞百白破-灭活脊髓灰质炎疫苗（REPEVAX®）的体液免疫。
Hum Vaccin. 2010 Oct;6(10):829-34. doi: 10.4161/hv.6.10.12582. Epub 2010 Oct 1.
引用本文的文献
1
Corresponding type-specificity of vibriocidal and agglutinating activities of Vibrio cholerae antisera: relevance to vaccine immunogenicity.霍乱弧菌抗血清的杀弧菌活性和凝集活性的相应型特异性：与疫苗免疫原性的相关性。
Epidemiol Infect. 1993 Jun;110(3):489-97. doi: 10.1017/s0950268800050913.
2
Accelerated immunisation with diphtheria-tetanus-pertussis vaccine.
BMJ. 1991 Sep 14;303(6803):648-9. doi: 10.1136/bmj.303.6803.648-c.
本文引用的文献
1
Immunologic response to early and routine DTP immunization in infants.婴儿对早期和常规百白破疫苗免疫接种的免疫反应。
Pediatrics. 1984 Jan;73(1):37-42.
2
Persistence of antibody after accelerated immunisation with diphtheria/tetanus/pertussis vaccine.白喉/破伤风/百日咳疫苗加速免疫后抗体的持续性。
BMJ. 1991 Jun 22;302(6791):1489-91. doi: 10.1136/bmj.302.6791.1489.
3
Some unsolved problems with vaccines.疫苗存在的一些未解决问题。
Prog Drug Res. 1979;23:9-26. doi: 10.1007/978-3-0348-7105-1_1.
Zotero 插件